Drugs / LX1031
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00813098 | Dec 2008 → Jul 2009 | irritable bowel syndrome | Lexicon Pharmaceuticals | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LX1031 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00813098 ↗ |
| Route | Oral | “daily oral intake” NCT00813098 ↗ |